A Detailed Analysis of the CGRP Inhibitors Market Based on the Remarkably Increasing Awareness Regarding Signs, Symptoms, and Treatment of Migraine
Industry: Healthcare
Published Date: January-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 213
Report ID: PMRREP33710
1. Executive Summary
1.1. Global CGRP Inhibitors Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Molecule Lifecycle Analysis
2.4. CGRP Inhibitors Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global CGRP Inhibitors Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global CGRP Inhibitors Market Outlook: Molecule
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Molecule, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Molecule, 2023 - 2030
3.3.3.1. Small Molecule
3.3.3.2. Large Molecule
3.4. Market Attractiveness Analysis: Molecule
3.5. Global CGRP Inhibitors Market Outlook: Treatment
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Treatment, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment, 2023 - 2030
3.5.3.1. Preventive Migraine Treatment
3.5.3.2. Acute Migraine Treatment
3.6. Market Attractiveness Analysis: Treatment
3.7. Global CGRP Inhibitors Market Outlook: Route of Administration
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Route of Administration, 2018 - 2022
3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030
3.7.3.1. Oral
3.7.3.2. Nasal
3.7.3.3. Injectables
3.8. Market Attractiveness Analysis: Route of Administration
3.9. Global CGRP Inhibitors Market Outlook: End User
3.9.1. Introduction / Key Findings
3.9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
3.9.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
3.9.3.1. Hospitals
3.9.3.2. Specialty clinics
3.9.3.3. Mail order pharmacies
3.9.3.4. Retail Pharmacies
3.10. Market Attractiveness Analysis: End User
4. Global CGRP Inhibitors Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia & Pacific
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America CGRP Inhibitors Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Molecule
5.3.3. By Treatment
5.3.4. By Route of Administration
5.3.5. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Molecule, 2023 - 2030
5.5.1. Small Molecule
5.5.2. Large Molecule
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment, 2023 - 2030
5.6.1. Preventive Migraine Treatment
5.6.2. Acute Migraine Treatment
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030
5.7.1. Oral
5.7.2. Nasal
5.7.3. Injectables
5.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
5.8.1. Hospitals
5.8.2. Specialty clinics
5.8.3. Mail order pharmacies
5.8.4. Retail Pharmacies
5.9. Market Attractiveness Analysis
6. Europe CGRP Inhibitors Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Molecule
6.3.3. By Treatment
6.3.4. By Route of Administration
6.3.5. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Turkey
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Molecule, 2023 - 2030
6.5.1. Small Molecule
6.5.2. Large Molecule
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment, 2023 - 2030
6.6.1. Preventive Migraine Treatment
6.6.2. Acute Migraine Treatment
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030
6.7.1. Oral
6.7.2. Nasal
6.7.3. Injectables
6.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
6.8.1. Hospitals
6.8.2. Specialty clinics
6.8.3. Mail order pharmacies
6.8.4. Retail Pharmacies
6.9. Market Attractiveness Analysis
7. East Asia CGRP Inhibitors Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Molecule
7.3.3. By Treatment
7.3.4. By Route of Administration
7.3.5. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Molecule, 2023 - 2030
7.5.1. Small Molecule
7.5.2. Large Molecule
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment, 2023 - 2030
7.6.1. Preventive Migraine Treatment
7.6.2. Acute Migraine Treatment
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030
7.7.1. Oral
7.7.2. Nasal
7.7.3. Injectables
7.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
7.8.1. Hospitals
7.8.2. Specialty clinics
7.8.3. Mail order pharmacies
7.8.4. Retail Pharmacies
7.9. Market Attractiveness Analysis
8. South Asia & Oceania CGRP Inhibitors Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Molecule
8.3.3. By Treatment
8.3.4. By Route of Administration
8.3.5. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Molecule, 2023 - 2030
8.5.1. Small Molecule
8.5.2. Large Molecule
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment, 2023 - 2030
8.6.1. Preventive Migraine Treatment
8.6.2. Acute Migraine Treatment
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030
8.7.1. Oral
8.7.2. Nasal
8.7.3. Injectables
8.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
8.8.1. Hospitals
8.8.2. Specialty clinics
8.8.3. Mail order pharmacies
8.8.4. Retail Pharmacies
8.9. Market Attractiveness Analysis
9. Latin America CGRP Inhibitors Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Molecule
9.3.3. By Treatment
9.3.4. By Route of Administration
9.3.5. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Molecule, 2023 - 2030
9.5.1. Small Molecule
9.5.2. Large Molecule
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment, 2023 - 2030
9.6.1. Preventive Migraine Treatment
9.6.2. Acute Migraine Treatment
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030
9.7.1. Oral
9.7.2. Nasal
9.7.3. Injectables
9.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
9.8.1. Hospitals
9.8.2. Specialty clinics
9.8.3. Mail order pharmacies
9.8.4. Retail Pharmacies
9.9. Market Attractiveness Analysis
10. Middle East & Africa CGRP Inhibitors Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Molecule
10.3.3. By Treatment
10.3.4. By Route of Administration
10.3.5. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Molecule, 2023 - 2030
10.5.1. Small Molecule
10.5.2. Large Molecule
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment, 2023 - 2030
10.6.1. Preventive Migraine Treatment
10.6.2. Acute Migraine Treatment
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030
10.7.1. Oral
10.7.2. Nasal
10.7.3. Injectables
10.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
10.8.1. Hospitals
10.8.2. Specialty clinics
10.8.3. Mail order pharmacies
10.8.4. Retail Pharmacies
10.9. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Large Molecule
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Amgen
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Novartis
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. Teva Pharmaceutical Industries Ltd.
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Eli Lilly
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Lundbeck
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. Abbvie
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Allergan
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
